Keratitis News and Research

RSS
New contact lens microbiology workshop aims at preventing Acanthamoeba keratitis

New contact lens microbiology workshop aims at preventing Acanthamoeba keratitis

Integrated therapies can reduce depression by half among people with low vision due to AMD

Integrated therapies can reduce depression by half among people with low vision due to AMD

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

AbbVie releases preliminary results from ABT-414 Phase I study in patients with recurrent or unresectable GBM

AbbVie releases preliminary results from ABT-414 Phase I study in patients with recurrent or unresectable GBM

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

ImmunoGen presents first findings aimed at optimizing dosage of IMGN853 product candidate

ImmunoGen presents first findings aimed at optimizing dosage of IMGN853 product candidate

Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions enters into definitive agreement to acquire Cangene

IBN and IBM discover new medical application for converted PET bottles

IBN and IBM discover new medical application for converted PET bottles

New material effective in destroying drug-resistant fungi

New material effective in destroying drug-resistant fungi

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

Nanomedicine Award winners officially announced at BIO-Europe conference

Nanomedicine Award winners officially announced at BIO-Europe conference

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides files Orphan Drug application with FDA for DengueCide

Ophthalmologists warn that overexposure to sun's UV rays can cause temporary blindness

Ophthalmologists warn that overexposure to sun's UV rays can cause temporary blindness

FDA approves PROLENSA for treatment of inflammation, pain after cataract surgery

FDA approves PROLENSA for treatment of inflammation, pain after cataract surgery